• AIM: To assess if the included vascular endothelial growth factor (VEGF) polymorphisms rs3025035, rs3025021 and rs2010963 are associated to proliferative retinopathy in a Mexican population with type 2 diabetes mellitus (T2DM).
• CONCLUSION: This is the first analysis involving VEGFA polymorphisms and proliferative diabetic retinopathy in a Mexican population. A major finding of the present study is that none of the polymorphisms studied was significantly associated with proliferative retinopathy. Based on these results, we can infer that different populations have different associations for the same polymorphisms.
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INTRODUCTION
T ype 2 diabetes mellitus (T2DM) is a multifactorial disorder that has reached epidemic proportions worldwide. The incidence of T2DM is predicted to rise substantially over the next few decades [1] [2] [3] . T2DM is characterized by chronic elevation of blood glucose levels due to peripheral insulin resistance [4] , pericyte apoptosis is the most specific vascular pathology attributed to hyperglycemia [5] [6] [7] . The subsequent pathological damage involve injury to endothelial cell and blood vessels´ basal membrane, which leads to retinal blood supply impairment and ischemia; resulting in subsequent formation of abnormal new vessels (retinal neovascularization) [7] . The ischemic cues, generated on the retina, lead to massive production of vascular endothelial growth factor (VEGF), a multifunctional cytokine that promotes angiogenesis and a potent mediator of microvascular permeability [8] . VEGF is largely responsible for the pathological production of neo-vessels in diabetic retinopathy; leading to severe complications and irreversible loss of vision [9] . Several studies have shown that susceptibility to proliferative diabetic retinopathy (PDR) also has a genetic component, independent of glycemic control and duration of diabetes [10] [11] [12] . Several single nucleotide polymorphisms (SNP) have been described in the VEGF gene, some of which have been reported to increase VEGF expression in vitro [13] [14] . A series of previous studies reported association of VEGF SNP with PDR and macular edema [15] [16] . The SNP, rs3025035, rs3025021 and rs2010963 have previously been associated to PDR in several populations; however to our knowledge there are no studies regarding the behavior of these SNP in a Mexican-based population [17] [18] [19] . The aim of this study was to determine whether rs3025035, rs3025021 and rs2010963 SNP in the VEGF gene are associated with PDR in a Mexican population with T2DM.
SUBJECTS AND METHODS
Study Design This case control study was performed at the Asociation to Prevent Blindness in Mexico Hospital (APEC) and at the School of Medicine of the Autonomous University of Queretaro (SM-UAQ). The internal review board of the Asociation to Prevent Blindness in Mexico and the Bioethical Committee of SM-UAQ revised and approved this study. This study was conducted in accordance to the tenets of the Declaration of Helsinki and Good Clinical Practices Guidelines. All participants were briefed extensively and signed a written informed consent form before any study procedures were performed. Sensible data was handled in accordance to the health insurance portability and accountability act. The study enrolled patients with clinical and laboratorial diagnosis of T2DM from Oct. 2014 to Jun. 2015 from the Retina Department of the APEC. All participants were born in Mexico from parents and grandparents whom identified themselves as Mexican mestizos. The inclusion criteria were patients with T2DM, aged 18y or older and diagnosed at least 5y before the time of their enrollment in study. Diagnosis of T2DM was made according to World Health Organization criteria [20] . All of the subjects had a comprehensive ocular examination including a review of the medical history, slit-lamp examination, Goldmann applanation tonometry, dilated fundus examination and seven-field digital fundus photography with fluorescence angiograph. Classification of severity of retinopathy was based according to the Early Treatment Diabetic Retinopathy Study (ETDRS) standardization protocols [13] . DNA Extraction and Genotyping Genomic DNA was extracted from whole fresh blood by using the Wizard Genomic DNA Purification kit (Promega, Madison WI, USA), according to manufacturer instructions. Concentrations of purified DNA samples were spectrophotometrically determined and adjusted to 20-50 ng/mL. Genotyping for rs2010963, rs3025021 and rs3025035 were performed by using TaqMan ® SNP Genotyp- . Linkage disequilibrium was calculated by employing the Cube X online software [22] . RESULTS A total of 142 patients were enrolled in the study, clinical and demographic data are summarized on Table 1 . There were no statistically significant differences between the NPDR and the PDR groups in terms of age, duration of the diabetes, age of T2DM onset, serum glucose and HbA1c levels. Nevertheless, the means for age, duration of the diabetes, age of T2DM onset were superior in the PDR group. Table 3 , association tests with PDR were non-significant for all three SNP. Haplotype analyses were also not significantly associated to PDR (data not shown). DISCUSSION This is the first analysis involving VEGFA polymorphisms and PDR in a Mexican population. A major finding of the present study was that none of the SNP studied was significantly associated with PDR. Previous studies have shown association of these SNP with PDR, although it was not found to be significantly associated with PDR in our study. Al-Kateb et al [23] and Abhary et al [2] found rs3025021 to be associated to PDR severity in Caucasian population from Canada and Australia, respectively, whereas Yang et al [24] found no significant association with PDR in Chinese population. In another study, Awata et al [16] found the rs2010963 C allele to be associated with macular edema and the presence of diabetic retinopathy in a Japanese based population study. Nevertheless, his findings contrast with those reported by Freathy et al [25] and Yang et al [24] who found no association between rs2010963 SNP and PDR in UK, and Chinese populations, respectively. In addition, Churchill et al [18] found that the haplotype formed by rs2010963 and rs1570360, was significantly associated with T2DM without retinopathy in a UK sample, thus highlighting the controversial role of the rs2010963 SNP. Regarding this SNP, a Meta-analysis published by Han et al [26] confirms the lack of association Fisher's exact test was employed for the analysis of this contingency across all studies performed in Asian and Australian populations. Based on these results, we can infer that different populations have different associations for the same SNP. In our study, there were no statistically significant differences in age, HbA1c and serum glucose levels in the patients from both groups; thus eliminating age, glucose and HbA1c serum levels as a potential bias. These findings could be partially explained considering the limited availability of health care services for the population living in remote and distant locations, which constitutes a major segment of the patients included in this study. Therefore, precarious metabolic conditions would be expected in a significant number of patients regardless of the T2DM age of onset, serum glucose or HbA1c levels. In addition, the linkage disequilibrium pairwise analyses for rs3025021 and rs3025035 showed that these SNP are simultaneously inherited. The rest of pairwise analyses showed no statistical significance, which strongly suggest that the last SNP (the rs2010963 polymorphism) has an independent hereditary pattern, which has not been previously reported in this population. These findings are expected considering that rs3025021 and rs3025035 are located in contiguous introns (6 and 7, respectively) within the VEGF gene, whereas the rs2010963 is located in the first intron of VEGF gene far upstream from the other SNP location.
Several limitations in this study should be noted, one of the main weaknesses of this study include the low sample size; however, our sample size calculation was performed in order to detect a minimal OR of 2.7, which is reasonable considering previous reports [2, [15] [16] 18] . Another limitation is the lack of clinical data regarding microvascular complications related to secondary diseases (i.e. hypertension, dyslipidemia or nephropathy) and pharmacological treatment in the studied population. Nonetheless this lack of information should not alter our results, since the treatment was not our focus and no significant differences in the clinical and biochemical features studied were found between both groups. In conclusion, previously reported association between these SNP and PDR varies depending on the studied population. The detection of potential associations between polymorphisms and PDR in Mexican population could allow health care providers to offer a more efficient diabetic retinopathy screening process, as well as to offer an early treatment when needed. Larger studies with independent replication are needed with larger sample sizes to confirm and further support these findings and their clinical importance.
